Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma.

In conclusion, methylated PTPRF, HOXD3, HOXD13 and CACNA1A are potential markers and may be utilized for the diagnosis and therapy of lung adenocarcinoma. PMID: 29467875 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/29467875?dopt=Abstract

Source: Oncology Letters - February 24, 2018 Category: Cancer & Oncology Tags: Oncol Lett Source Type: research